2016 American Transplant Congress
Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score.
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…2016 American Transplant Congress
Don't Judge a Book by Its Cover: Normal Liver Enzymes After Transplantation Can Be Associated with Pathologies Requiring Intervention.
Background:Liver biopsies are employed post-transplant generally to evaluate abnormal liver enzymes (LE); however they are not without risk. Whether post-transplant protocol biopsies (PB) serve any…2016 American Transplant Congress
National Trends of Acute Myocardial Infarction and Percutaneous Interventions in Liver Transplant Hospitalizations from 2006-2012.
RMTI, Icahn School of Medicine at Mount Sinai, New York, NY.
Introduction: Kidney transplantation has been associated with increased cardiovascular risk but the national epidemiology of acute myocardial infarctions (AMI) and percutaneous interventions (PCI) has not…2016 American Transplant Congress
Effect of Donor-Recipient Gender Mismatch in Liver Transplant Recipients: A Post-Hoc Analysis of the H2304 Study.
H2304 study group, Hamburg, Germany.
Purpose: Donor-recipient gender mismatch may play a role in liver transplant (LTx) outcomes. Here we present the 24-month results from the post-hoc analysis of the…2016 American Transplant Congress
Living Donor Liver Transplantation for Children With Biliary Atresia in the Pediatric End-Stage Liver Disease Era: The Role of Age and Insurance Status.
Lower socioeconomic status has been linked to inferior health outcomes. We have previously shown that children with biliary atresia (BA) who have public insurance (PU)…2016 American Transplant Congress
Initial Experience with Ledipasvir-Sofosbuvir Based Therapy for Recurrent Hepatitis C After Liver Transplantation.
Henry Ford Hospital, Detroit, MI.
Objectives:Evaluate outcomes of Ledipasvir-Sofosbuvir based hepatitis C therapy in liver transplant patients at a single center.Methods:All post-liver transplant patients started on Ledipasvir-Sofosbuvir therapy between January…2016 American Transplant Congress
Early Proteomic Predictors of Late Chronic Kidney Disease in Liver Transplant Recipients.
1Northwestern, Chicago; 2Baylor, Dallas.
Background: A high proportion of patients develop chronic kidney disease (CKD) after liver transplantation (LT). However, the ability to better select patients for nephroprotective interventions…2016 American Transplant Congress
The Impact of CMS Policy on Delisting of "Too Sick" Liver Transplant Candidates.
Surgery, UMass Medical School, Worcester, MA.
Background: The Model for End Stage Liver Disease (MELD)-based allocation system (2002) transformed liver transplant waitlist mortality by prioritizing the “sickest first.” We examine the…2016 American Transplant Congress
Clinical Rejection-Risk Assessment with Allospecific CD154+T-Cytotoxic Memory Cells (CD154+TcM) After Pediatric Liver or Intestine Transplantation (LTx, ITx).
Surgery, Children's Hosp of Pgh of UPMC & Univ of Pittsburgh, Pittsburgh, PA.
Background: In preclinical evaluation, CD154+TcM predict acute cellular rejection after LTx or ITx with sensitivity/specificity of 80%. Purpose/Methods: To summarize test indications and performance during…2015 American Transplant Congress
Domino Liver Transplant from Donors With MSUD: Operative Strategy and Long-Term Outcomes
Liver transplant (txp) is the definitive branched chain keto-acid (BCKA) replacement therapy for patients with Maple Syrup Urine Disease (MSUD). Due to the extra-hepatic distribution…
- « Previous Page
- 1
- …
- 160
- 161
- 162
- 163
- 164
- …
- 180
- Next Page »